Eden Research (LON:EDEN) Stock Price Down 8.3% – Should You Sell?

Eden Research plc (LON:EDEN) shares dropped 8.3% during trading on Friday . The company traded as low as GBX 3.30 ($0.04) and last traded at GBX 3.30 ($0.04). Approximately 280,171 shares changed hands during trading, a decline of 70% from the average daily volume of 928,276 shares. The stock had previously closed at GBX 3.60 ($0.05).

Eden Research Stock Down 8.3 %

The company has a market cap of £17.60 million, a price-to-earnings ratio of -11.56 and a beta of 0.92. The company has a current ratio of 3.80, a quick ratio of 2.42 and a debt-to-equity ratio of 1.26. The firm’s fifty day moving average price is GBX 3.88 and its 200-day moving average price is GBX 3.95.

Insider Activity at Eden Research

In other Eden Research news, insider Lykele van der Broek purchased 256,000 shares of the company’s stock in a transaction dated Thursday, February 6th. The stock was purchased at an average price of GBX 4 ($0.05) per share, with a total value of £10,240 ($12,975.16). Also, insider Alexander John Abrey purchased 540,540 shares of Eden Research stock in a transaction on Tuesday, January 28th. The stock was bought at an average price of GBX 4 ($0.05) per share, with a total value of £21,621.60 ($27,396.86). 14.02% of the stock is currently owned by insiders.

Eden Research Company Profile

Eden Research is the only UK-listed company focused on biopesticides for sustainable agriculture. It develops and supplies innovative biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries.

Eden’s products are formulated with terpene active ingredients, based on natural plant defence metabolites.